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As a result of recent reports and enthusiasm for video-assisted thorascopic 
pericardiectomy, we reviewed our experience with subxiphoid pericardial drainage. 
From August 15, 1988, to June 7, 1993, 155 patients underwent subxiphoid 
pericardial drainage for pericardial efl'usion associated with pericardial tamponade. 
The group comprised 85 female (55%) and 70 male patients whose ages ranged from 
5 weeks to 88 years. The procedure was carried out with general anesthesia in 113 
patients (72%) and with local anesthesia nd sedation in 42 patients. Underlying 
cancer was present in 82 patients; 73 patients had benign disease. Follow-up is 
complete in all patients. The overall 30-day mortality was 20%; in patients with 
cancer it was 32.9% (27/82) versus 5.4% (4/73) for patients with benign disease. No 
postoperative death was attributed to the surgical procedure. Recurrent pericardial 
tamponade necessitating further surgical intervention occurred in four patients 
(2.5%), two with cancer (2.4%) and two with benign disease (2.7%). Median survivai 
after subxiphoid pericardial drainage in patients with benign disease was more than 
800 days versus 83 days in patients with cancer (p < 0.01). Median survival after 
pericardial drainage in patients with cancer who had malignant pericardial effusion 
was 56 days compared with 105 days for patients with cancer who did not have tumor 
in the pericardium (p < 0.05). We believe that subxiphoid drainage is the procedure 
of choice for patients with pericardial tamponade. It is accomplished quickly, is 
associated with minimal morbidity, and prevents recurrent tamponade in 97.4% 
(151/155) of patients. (J TrlORAC CARDIOVASC SURG 1995;109:546-52) 
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0 ardiac tamponade is defined as hemodynamically significant cardiac compression by accumulating 
pericardial contents that evokes and defeats com- 
pensating mechanisms. 1 A wide variety of patho- 
logic conditions may cause pericardial etNsion lead- 
ing to pericardial tamponade. Cardiac tamponade 
requires drainage to prevent cardiac decompensa- 
tion and death. The effusion can be drained by 
needle or catheter pericardiocentesis, z-4 subxiphoid 
pericardial drainage, 5-17 pericardial window per- 
formed through a left anterior thoracotomy, 5' ~8, 19 
pericardiectomy performed by an open thoracot- 
omy, 1s'19 or video-assisted thorascopic (VATS) 
pericardiectomy. 2°-22 The most effective method of 
drainage to prevent recurrence is subject to contro- 
versy. 
Patients and methods 
Patients. We reviewed the records of 155 patients with 
pericardial effusion who underwent subxiphoid pericardial 
window for pericardial effusion associated with pericardial 
tamponade from August 15, 1988, to June 7, 1993. The 
546  
patients were treated at Rush-Presbyterian-St. Luke's 
Medical Center, Chicago, Illinois (89 patients), or Albany 
Medical Center, Albany, New York (66 patients). There 
were 85 female patients (55%) and 70 male patients 
whose ages ranged from 5 weeks to 88 years. The proce- 
dure was carried out with general anesthesia in 113 
patients (72%) or with local anesthesia nd sedation in 
42 patients. Cancer was present in 82 patients; 42 of these 
patients had malignant effusion and 40 did not have tumor 
within the pericardium according to cytologic and histo- 
logic analyses (Table I). Seventy-three patients had benign 
disease (Table II). Cardiac tamponade was diagnosed on 
the basis of subjective symptoms, physical signs, chest 
roentgenography, electroeardiography, and echocardiog- 
raphy. Recurrence of tamponde was defined as a need for 
further surgical intervention. Follow-up is complete in all 
patients. 
Surgieal technique. General anesthesia s preferred for 
performing subxiphoid pericardial drainage, hut the pro- 
cedure may be performed with local anesthesia plus 
adequate sedation in the patient with severe tamponade 
who cannot tolerate g neral anesthesia. If general anes- 
thesia is used, the patient's kin is prepared and draped 
before induction of anesthesia to avoid delay if hypoten- 
sion develops. 
A small incision is made from the lower end of the 
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Table I. Tumor types in patients with cancer 
Type No. of cases 
Lung 30 (36.5%) 
Breast 23 (28%) 
Lymphoma 7 
Mesothelioma 5 
Other primary tumor 7 
Gastric 2 
Sarcoma 3 
Thymoma 2 
Unknown prirnary tumor 3 
Total 82 
Table II. Diagnosis in patients with benign disease 
Diagnosis No. of cases 
Postcardiotomy syndrome 17 
Connective tissue disease 10 
Chronic renal failure 9 
Viral pericarditis 9 
Human immunodeficiency virus 6 
Tuberculosis 3 
Congestive heart failure 3 
Hernophilus influenzae 2 
Idiopathic 14 
Total 73 Fig. 1. Close-up view of pericardial drainage technique. 
sternum caudally for approximately 6 to 8 cm. The upper 
linea alba is divided in the midlinë and the xiphoid 
sternum is split or resected. The peritoneum is not 
opened. The tissue plane between the posterior wall of the 
sternum and the anterior pericardium is developed by 
blunt finger dissection. A small retractor is placed in the 
abdominal incision and a right-angled retractor isused to 
elevate the distal sternum. The anterior pericardium is
incised; the fluid is drained (Fig. 1) and is sent for 
bacteriologic and cytologic analyses. The pericardium is
explored igitally to identify adhesions or tumor deposits. 
A piece of pericardium approximately 2 to 3 cm in 
diameter is excised and submitted for bacteriologic and 
histologic analyses (Fig. 1). Through a separate stab 
wound in the left upper part of the abdomen, a 28 F chest 
tube is placed through the pericardiotomy for postopera- 
tive suction drainage (Fig. 2). It is important to place the 
chest tube through a separate incision because a chest 
tube left in the operative wound can lead to improper 
wound healing, wound infection, and incisional hernia. 
The pericardial incision is left open; the abdominal inci- 
sion is closed with interrupted or running absorbable 
sutures. The chest ube is left in place for 4 to 5 days after 
the operation. 
Statistlcal methods. The data were analyzed by means 
of SAS (Statistical Analysis Systems, Inc., Cary, N.C.). 
The Lifetest Procedure was used to estimate the means 
and medians that are reported. The Gehan (Wilcoxon) 
test 23 was used to estimate p values when comparing 
survival distributions. Survival curves are plotted by the 
Kaplan-Meier method. 
Results 
Operative mortality, defined as death within 30 
days of operation or during the same hospitaliza- 
tion, occurred in 31 patients (20%). The 30-day 
postoperative mortality in patients with cancer was 
32.9% (27/82) and in patients with benign disease, 
5.4% (4/73). The causes of death of the four patients 
with benign disease who died in the postoperative 
period are summarized in Table III. None of the 
postoperative deaths was attributed to the surgical 
procedure. Recurrent pericardial tamponade, ne, 
cessitating further surgical intervention, occurred in 
four patients (2.5%): two patients with cancer (2/82, 
2.4%) and two patients with benign disease (2/73, 
2.7%). Recurrent tamponade did not develop in any 
patient with malignant pericardial effusion. Median 
survival after subxiphoid pericardial drainage in 
patients with benign disease was rnore than 800 days 
versus 83 days in patients with cancer (p < 0.01). 
Median survival after pericardial drainage in pa- 
tients with cancer who had malignant pericardial 
effusion was 56 days, compared with 105 days for 
patients with cancer who did not have malignant 
effusion (p < 0.05, Fig. 3). All but one of the 42 
patients with rnalignant pericardial effusion have 
died of their disease (mean follow-up 107 days). 
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Fig. 2. Placement of pericardiostomy tube through a 
separate stab wound in the left upper quadrant. 
One patient with breast cancer who had a malignant 
effusion is alive without recurrent pericardial tam- 
ponade at 2.2 years. Fifteen of the 40 patients with 
cancer but benign effusion (5 lung, 6 breast, and 4 
other) were alive at the time of analysis and 25 have 
died of their disease (62.5%) (mean follow-up 264 
days). 
Thirty patients with lung cancer had a median 
survival after subxiphoid pericardial drainage of 56 
days. Twenty-three patients with breast cancer had a 
median survival of 195 days. Twenty-nine patients 
with other tumors had a median survival of 46 days 
after pericardial drainage (p < 0.01, Fig. 4, Table 
IV). Among patients with malignant pericardial 
effusion, those with breast cancer had significantly 
better survival after drainage than patients with 
either lung or other types of cancer 6o < 0.01, Fig. 
5). 
Within this series eight patients had human im- 
munodeficiency virus infection, and two of them had 
malignant effusion resulting from lymphoma; no 
tumor or specific causative agent was identified in 
six patients. All eight patients with human immuno- 
deficiency virus died without recurrent pericardial 
tamponade; mean follow-up was 130 days. 
In all eight patients on whom autopsy was per- 
Table III. Postoperative mortality in patients with 
benign disease 
Tirne to death Cause of death 
48 hr 
13 days 
20 days 
25 days 
Pneumonia, sepsis, multiorgan failure 
Perforated colon, sepsis, multiorgan 
failure 
Juvenile rheumatoid arthritis, tubercu- 
losis 
Human immunodeficiency virus, sepsis, 
multiorgan failure 
formed, the potential pericardial space was fused 
with dense adhesions between the pericardium and 
epicardium. 
Discussion 
Patients with pericardial tamponade are critically 
ill and require expeditious drainage of the pericar- 
dial space. Pericardiocentesis may provide tempo- 
rary relief of tamponade but is not adequate for 
definitive therapy. In a series of 36 patients with 
pericardial tamponade reported by Markiewicz, 
Borovik, and Ecker 2 in 1986, 83% of the patients 
had recurrent amponade after successful needle 
pericardiocentesis. Wong and associates 3 reported a
series of 52 patients with peri¢ardial tamponade 
who were treated with pericardiocentesis. Seventeen 
of the 52 patients (32%) had unproductive or un- 
successful pericardiocentesis and eight of the 52 
patients (15%) had serious complications. These 
complications included one death, one cardiac ar- 
rest, one aspiration of a subdiaphragmatic abscess, 
and five ventricular punctures without adverse se- 
quelae. 
Piehler and bis associates is (1985), after eview of 
145 patients with pericardial effusion treated by 
surgical drainage, suggested a direct relationship 
between the extent of pericardial resection and the 
incidence of recurrent effusion. These authors ad- 
vocate complete pericardiectomy rather than subxi- 
phoid drainage or pericardial window created by 
anterior thoracotomy. Within their series, however, 
only 13 patients underwent subxiphoid drainage, 
and only one of the 13 required reoperation (7.7%). 
Five patients in this series who underwent transtho- 
racic pericardial window required reoperation (5/24, 
20.8%). These numbers are too small to allow 
meaningful statistical analysis or to adequately as- 
sess the effectiveness of subxiphoid rainage. Naun- 
heim and colleagues 5 (1991) report no significant 
difference in survival or freedom from recurrent 
effusion between patients treated by subxiphoid or 
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Fig. 3. Survival for all patients. Patients with benign disease had significantly onger median survival than 
patients with cancer. Patients with cancer and benign effusion had significantly onger median survival than 
patients with malignant pericardial effusion. 
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Fig. 4. Survival for patients with cancer by tumor type. Patients with breast cancer had significantly onger 
median survival than patients with lung or other types of cancer. 
transthoracic drainage. In this series, postoperative 
respiratory complications were more prevalent in 
patients treated by transthoracic drainage than in 
patients treated by subxiphoid rainage. 
Reports of high recurrence rates after pericardial 
drainage 1,18, 24 have led to interest in VATS peri- 
cardiectomy. 2°'22 Advocates of VATS pericardiec- 
tomy point out that it allows for a large pericardial 
resection, as recommended by Piehler and col- 
leagues. 18 Out data suggest that a large pericardiec- 
tomy is not necessary. VATS pericardiectomy neces- 
sitates general anesthesia and single lung anesthesia 
in all cases, and patients with pericardial tamponade 
also require needle pericardiocentesis before VATS 
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Fig. 5. Survival for patients with malignant pericardial effusion. Patients with breast cancer had signifi- 
cantly longer median survival than patients with lung or other types of cancer. 
Table IV. Median survival of patients with cancer 
Median 
No. of survival Range 
Tumor type patients (days) (days) 
Breast--overall 23 195 
Malignant etNsion 13 114 25-180 
Benign effusion 10 >800 1-1460 
Lung-- overall 30 56 
Malignant effusion 13 73 4-223 
Benign effusion 17 56 1-447 
Other-- overall 29 46 
Malignant effusion 16 21 1-497 
Benign effusion 13 95 7-1247 
pericardiectomy. These are significant consider- 
ations in these gravely ill patients. 
Early pericardiectomy has been advocated for 
patients with pericardial effusion resulting from 
Hemophilus influenzae 5'25 and tuberculosis. »' 19 In 
our series, tuberculous pericarditis was successf~lly 
controUed by subxiphoid rainage in all three pa- 
tients with this complication. Subxiphoid drainage 
was unsuccessful in one of two patients with He- 
mophilus influenzae pericarditis, and pericardiec- 
tomy was necessary. For patients with infectious 
pericardial effusion it seems rational to perform 
subxiphoid rainage as the initial procedure, pro- 
vided that the patients are monitored closely for 
evidence of recurrent tamponade or constriction. 
Sugimoto and his colleagues 17(1990) suggest that 
the success of pericardial drainage is dependent on 
obliteration of the pericardial space by adhesions. 
Our experience adds further support o this theory. 
All eight of our patients who underwent autopsy 
were found to have obliteration of the pericardial 
space by dense adhesions. The surgical technique 
that we use does not create a pericardial window 
into the peritoneal space. The pericardium is ap- 
proached extraperitoneally. We believe that postop- 
erative tube suction drainage allows adhesions to 
form between the pericardium and epicardium, thus 
obliterating the pericardial space and preventing 
reaccumulation f fluid. 
Out study confirms that patients with malignant 
pericardial effusion causing tamponade have a very 
limited life expectancy. There is a significant differ- 
ence in survival, however, between patients with 
malignant effusion and those with underlying cancer 
who do not have tumor within the pericardium (see 
Fig. 3). This differentiation is important and should 
be taken into consideration when planning long- 
term care of these patients. 
In summary, our experience l ads us to conclude 
that subxiphoid pericardial drainage provides expe- 
ditious, effective, and durable treatment, with low 
morbidity, for pericardial tamponade from all 
causes. We believe it is the procedure of choice for 
patients with pericardial tamponade. 
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Discussion 
Dr. Joseph I. Miller (Atlanta, Ga.). On the basis of 
earlier experience from 1974 to 1978, we found a 4.5% 
incidence of recurrenee after subxiphoid drainage for 
benign disease. It may be that the tubes were left in place 
for too short a time. A fair number of these procedures 
were done for purulent pericarditis and viremic type 
infections. Starting in 1978 we switched to left parietal 
pericardiectomy. We have done 248 of these procedures 
with five hospital deaths and no recurrence in the group. 
I agree that subxiphoid drainage is appropriate for 
malignant disease caused by lung cancer. However, I still 
advocate that the standard pericardiectomy through a left 
thoracotomy requires about a 45-minute operating time 
and has an operative mortality of about 1% to 1.5%. I am 
not sure that standard pericardiectomy should be aban- 
doned in favor of this operation for the entire group of 
patients with effusive pericardial disease. 
Dr. Norman J. Snow (Cleveland, Ohio). We have a 
smaller series in Cleveland of about 53 patients, but the 
results are similar. The recurrence rate is 3.8%. One 
recurrence was due to use of a sump drain instead of 
negative suction, and the other was due to systemic 
disease rather than surgical technique. 
Mortality was likewise low; one death occurred in a 
patient who was taken to the operating room in a mori- 
bund condition, (that is a problem with patient selection) 
and one was a cardiac death from postoperative h mo- 
pericardium. 
A most important point is the change from the prelim- 
inary title of the paper, "Subxiphoid Pericardial Window," 
to the eurrent itle, "Pericardial Drainage." I think the 
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concept of the pericardial window should be eliminated 
from our lexicon and that drainage with negative pressure 
suction and apposition of parietal and visceral pericar- 
dium are the most important things to be learned hefe. 
Four or 5 days of suction is important. As soon as the 
tubes are inserted, our colleagues on the medical service 
are asking to remove them. Virtually all of the patients in 
a series such as this are going to be in the hospital for 4 to 
5 days because of their underlying disease, be it benign or 
malignant. Therefore, I see no particular advantage to 
anything that might facilitate earlier dismissal in this 
patient population. 
Are there any indications now for transthoracic drain- 
age of these effusions? Are there any reasons to accede to 
out oncologists' requests that we instill sclerosants or 
antineoplastic agents into the pericardium? 
Dr. Moores. The answers to your questions are no and 
no. In my opinion, the initial approach in almost every- 
body with pericardial tamponade should be subxiphoid 
drainage. We changed the title to pericardial drainage 
when we realized that we were not making a pericardial 
window. The term window in our work is a misnomer. The 
procedure we describe is a tube pericardiostomy. 
Sclerosing agents have a very limited role. There is 
usually a marked amount of inflammatory esponse in the 
pericardium of these patients, and this is adequate to 
cause the epicardium and the pericardium to stick. I do 
not think adding an irritant is necessary. 
Dr. Akio Wakabayashi (Orange, Calif). My comments 
relate to anesthesia for thoracoscopy. Before the double- 
lumen tube became available I did more than 200 cases of 
thoracoscopy with just a single regular endotracheal tube. 
This can be done, especially for a pericardial window 
drainage procedure, because the pericardium is so big and 
close to the left wall of the chest hat one-lung ventilation 
is not necessary, and for that, there is no difference 
between the subxiphoid approach and the thoracoscopy 
approach. I used to use the subxiphoid approach myself 
before I started to do pericardial window procedures 
through a left thoracoscopy. I find that thoracoscopy 
allows much bettet visualization and the option of how 
much of the pericardium can be taken. This is a personal 
choice, but I prefer a thoracoscopy approach. 
